Clinical application of Ghrelin

Current Pharmaceutical Design

Volumn 18, Issue 31, 2012, Pages 4800-4812

  Strasser, Florian ^a  

^a CANTONAL HOSPITAL ST GALLEN   (Switzerland)

Author keywords

Cachexia; Gastrointestinal motility; Ghrelin; Inflammation; Mood

Indexed keywords

17 METHYLNALTREXONE; ANAMORELIN; C REACTIVE PROTEIN; GHRELIN; GLUCAGON; GLUCOSE; GROWTH HORMONE; IBUTAMOREN; INSULIN; MOTILIN; PLACEBO; SOMATOSTATIN; ULIMORELIN;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ADVANCED CANCER; ALCOHOLISM; ANOREXIA NERVOSA; APPETITE DISORDER; ARTICLE; BODY COMPOSITION; BODY MASS; BODY WEIGHT; BONE MINERALIZATION; BREAST CANCER; CACHEXIA; CALORIC INTAKE; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONSTIPATION; CYSTIC FIBROSIS; DELTA RHYTHM; DIABETIC GASTROPARESIS; DIALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE COMPARISON; DRUG DOSE ESCALATION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; ELECTROENCEPHALOGRAM; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FLUSHING; FOOD INTAKE; GASTRECTOMY; GASTROINTESTINAL DISEASE; GASTROINTESTINAL MOTILITY; HAND GRIP; HEART FAILURE; HEART OUTPUT; HEART RATE; HEART STROKE VOLUME; HOME CARE; HORMONE SUBSTITUTION; HUMAN; HUNGER; HYPERHIDROSIS; IDIOPATHIC GASTROPARESIS; KIDNEY FAILURE; LONG TERM CARE; LOW DRUG DOSE; LUNG NON SMALL CELL CANCER; MAJOR DEPRESSION; NAUSEA; NEOPLASM; NONREM SLEEP; NUTRITIONAL HEALTH; OBESITY; PALLIATIVE THERAPY; PATIENT EDUCATION; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PHYSICAL ACTIVITY; POSTOPERATIVE CARE; POSTOPERATIVE ILEUS; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION PRESSURE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REM SLEEP; RESPIRATORY TRACT INFECTION; SIDE EFFECT; SLEEP; SLEEP WAKING CYCLE; SOMNOLENCE; STOMACH ACID SECRETION; STOMACH CANCER; STOMACH EMPTYING; STOMACH INNERVATION; STOMACH MOTILITY; STOMACH PARESIS; SYMPATHETIC REFLEX; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; UPPER GASTROINTESTINAL TRACT; VAGOTOMY; VISUAL ANALOG SCALE; VOMITING; WALKING; WASTING SYNDROME; WEIGHT REDUCTION; XEROSTOMIA;

ANIMALS; APPETITE REGULATION; APPETITE STIMULANTS; CACHEXIA; ENERGY METABOLISM; GASTROINTESTINAL AGENTS; GASTROINTESTINAL DISEASES; GASTROINTESTINAL MOTILITY; GHRELIN; HUMANS; RECEPTORS, GHRELIN; WASTING SYNDROME;

EID: 84866403161     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161212803216870     Document Type: Article

References (43)

1. Wren AM, Seal LJ, Cohen MA, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocr Metabol 2001; 86: 5992-5995.
2. Enomoto M, Nagaya N, Uematsu M, et al. Cardiovascular andhormonal effects of subcutaneous administration of ghrelin, a novel growth hormone-releasing peptide, in healthy humans Clin Science 2003; 105: 431-435.
3. Druce MR, Neary NM, Small CJ, et al. Subcutaneous administration of ghrelin stimulates energy intake in healthy lean human volunteers. Int J Obesity 2006; 30: 293-296.
4. Akamizu T, Takaya K, Irako T, et al. Pharmacokinetics, safety, and endocrine and appetite effects of ghrelin administration in young healthy subjects. Eur J Endocrin 2004; 150: 447-455.
5. Tack J, Depoortere I, Bisschops R, et al. Influence of ghrelin on interdigestive gastrointestinal motility in humans. Gut 2006; 55: 327-333.
6. Levin F, Edholm T, Schmidt PT, et al. Ghrelin stimulates gastric emptying and hunger in normal-weight humans. J Clin Endocrin Metabol 2006; 91: 3296-3302.
7. Lippl F, Erdmann J, Steiger A, et al. Low-dose ghrelin infusion-- evidence against a hormonal role in food intake. Regul Pept 2012; 174: 26-31.
8. Weikel JC, Wichniak A, Ising M, et al. Ghrelin promotes slowwave sleep in humans. Am Physiol Endocrinal Metab 2003; 284: E407-E415.
9. Kluge M, Gazea M, Schüssler P, et al. Ghrelin increases slow wave sleep and stage 2 sleep and decreases stage 1 sleep and REM sleep in elderly men but does not affect sleep in elderly women. Psychoneuroendocrinology 2010; 35: 297-304.
10. Kluge M, Riedl S, Uhr M, et al. Ghrelin affects the hypothalamuspituitary- thyroid axis in humans by increasing free thyroxine and decreasing TSH in plasma. Eur J Endocrinol. 2010 Jun; 162: 1059-165.
11. Kluge M, Schüssler P, Schmidt D, et al. Ghrelin suppresses secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) in women. J Clin Endocrinol Metab. 2012 Jan 18. Epub ahead of print
12. Nass R, Pezzoli SS, Oliveri MC, et al. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial. Ann Intern Med 2008; 149: 601-611.
13. Kumor K, Polvino W. Biologic activity of RC-1291, a novel oral Ghrelin mimetic for the treatment of cancer anorexia/cachexia: Results from a phase I randomized, double-blind, placebo-controlled clinical trial in healthy volunteers. Support Care Cancer 2006; 14:593.
14. Garcia JM, Polvino WJ., Effect on body weight and safety of RC- 1291, a novel, orally available ghrelin mimetic and growth hormone secretagogue: results of a phase I, randomized, placebocontrolled, multiple-dose study in healthy volunteers. The Oncologist 2007; 12: 594-600.
15. Koch A, Sanson E, Helm A, et al. Regulation and prognostic relevance of serum ghrelin concentrations in critical illness and sepsis. Critical Care 2010; 14: R94.
16. Hirayama H, Shiina T, Shima T, et al. Contrasting effects of ghrelin and des-acyl ghrelin on the lumbo-sacral defecation center and regulation of colorectal motility in rats. Neuro gastroentology Motility 2010; 22: 1124-1131.
17. Tack J, Depoortere I, Bisschops R, et al. Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis. Aliment Pharmacol Care 2005; 22: 847-853.
18. Murray CDR, Martin NM, Patterson M, et al. Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study. Gut 2005; 54: 1693-1698.
19. Horowitz M, Maddox A, Harding PE, et al. Effect of cisapride on gastric and esophageal emptying in insulin-dependent diabetes mellitus. Gastroenterology 1987; 92: 1899-1907.
20. Darwiche G, Bjorgell O, Thorsson O, et al. Correlation between simultaneous scintigraphic and ultrasonographic measurement of gastric emptying in patients with type 1 diabetes mellitus. J Ultrasound Med 2003; 22: 459-466.
21. Low PA, Benrud-Larson LM, Sletten DM, et al. Autonomic symptoms and diabetic neuropathy: a population-based study. Diabetes Care 2004; 27: 294.
22. Binn M, Albert C, Gougeon A, et al. Ghrelin gastrokinetic action in patients with neurogenic gastroparesis. Peptides 2006; 27: 1603-1606.
23. Akamizu T, Ivacura H, Ariyasu H, et al. Repeated administration of ghrelin to patients with functional dyspepsia: its effects on food intake and appetite. European J Endocrinology; 2008; 158: 491-498.
24. Wo JM, Ejskjaer N, Hellström PM, et al. Randomised clinical trial: ghrelin agonist TZP-101 relieves gastroparesis associated with severe nausea and vomiting--randomised clinical study subset data. Aliment Pharmacol Care 2011; 33: 679-688.
25. Popescu I, Fleshner PR, Pezzullo JC, et al. The Ghrelin agonist TZP-101 for management of postoperative ileus after partial colectomy: a randomized, dose-ranging, placebo-controlled clinical trial. Dis Colon Rectum 2010; 53: 126-134.
26. Yamamoto K, Takiguchi S, Miyata H, et al. Randomized phase II study of clinical effects of ghrelin after esophagectomy with gastric tube reconstruction. Surgery 2010; 48: 31-38.
27. Adachi S, Takiguchi S, Okada K, et al. Effects of ghrelin administration after total gastrectomy: a prospective, randomized, placebo-controlled phase II study. Gastroenterology 2010; 138: 1312-1320.
28. Neary N, Small CJ, Wren A, et al. Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. J Endocrin Metabol 2004; 89: 2832-2836.
29. Strasser F, Lutz TA, Maeder MT, et al. Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/ cachexia: a randomised, placebo-controlled, double-blind, double-crossover study. Br J Cancer 2008; 98: 300-38.
30. Lundholm K, Gunnebo L, Körner U, et al. Effects by daily long term provision of ghrelin to unselected weight-losing cancer patients: a randomized double-blind study. Cancer 2010; 116: 2044-2052.
31. Kodama T, Ashitani J, Matsumoto N, et al. Ghrelin treatment suppresses neutrophil-dominant inflammation in airways of patients with chronic respiratory infection. Pulm Pharmacol Ther 2008; 21: 774-779.
32. Nagaya N, Itoh T, Murakami S, et al. Treatment of cachexia with ghrelin in patients with COPD. Chest 2005; 128: 1187-193.
33. Wynne K, Giannitsopoulo K, Small CJ, et al. Subcutaneous ghrelin enhances acute food intake in malnourished patients who receive maintenance peritoneal dialysis: a randomized, placebo-controlled trial. J Am Soc Nephrol 2005; 16: 2111-2118.
34. Nagaya N, Miyatake K, Uematsu M, et al. Hemodynamic, renal, and hormonal effects of ghrelin infusion in patients with chronic heart failure. J Clin Endocrinol Metab 2001; 86: 5854-5859.
35. Nagaya N, Moriya J, Yasumura Y, et al. Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation 2004; 110: 3674-3679.
36. Kluge M, Schüssler P, Dresler M, et al. A double dissociation of memory impairments in major depression. J Psychiatr Res. 2011; 45: 421-426.
37. Asakawa A, Inui A, Kaga T, et al. A role of ghrelin in neuroendocrine and behavioral responses to stress in mice. Neuroendocrinology 2001; 44: 143-147.
38. Kristensson E, Sundqvist M, Astin M, et al. Acute psychological stress raises plasma ghrelin in the rat. Regul Pept 2006; 134: 114-17.
39. Lambert E, Lambert G, Ika-Sari C, et al. Ghrelin modulates sympathetic nervous system activity and stress response in lean and overweight men. Hypertension 2011; 58: 43-50.
40. Miljic D, Pekic S, Djurovic M, et al. Ghrelin has partial or no effect on appetite, growth hormone, prolactin, and cortisol release in patients with anorexia nervosa. J Endocrinol Metabolism 2006; 91: 1491-195.
41. Hotta M, Ohwada R, Akamizu T, et al. Ghrelin increases hunger and food intake in patients with restricting-type anorexia nervosa: a pilot study. Endocr J 2009; 56: 1119-1128.
42. Huda MSB, Durham BH, Wong SP, et al. Lack of an acute effect of ghrelin on markers of bone turnover in healthy controls and post-gastrectomy subjects. Bone 2007; 41: 406-413.
43. Seim I, Josh P, Cunningham P, et al. Ghrelin axis genes, peptides and receptors: recent findings and future challenges. Mole Cell Endocrinol 2011; 340: 3-9.